Fleshner Neil E.

Neil E. Fleshner serves as the Chief Medical Officer at POINT Biopharma Global Inc., a company focused on advancing innovative cancer therapies. His role involves overseeing the development and implementation of clinical strategies within the healthcare sector. From November 2, 2023, to December 27, 2023, Fleshner reported five public disclosures related to his activities at POINT Biopharma, with transaction amounts ranging from $571.3K to $211.8K. The largest disclosed move was an action recorded on December 27, 2023, valued at approximately $571.3K.